← SynDRA
SU-11274
SynDRA canonical compound SYN0056368 — structure-anchored drug synonym record
| Primary target(s) | MET |
|---|
| Mechanism of action | Hepatocyte growth factor receptor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
- Hepatocyte growth factor receptor inhibitor
- MET INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CD38
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- KCNH2
- SIRT1
- SIRT2
- SIRT3
Cross-references
Synonyms
- SCHEMBL93713
- SCHEMBL31016300
- GLXC-05191
- HMS3295E03
- HMS3654C17
- SB19370
- NCGC00165902-02
- SW219453-1
- N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide
Look up SU-11274 in the interactive SynDRA portal →